Breast Cancer Clinical Trials in Dallas

Showing 281-300 of 307 trials

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

NCT00894504

In this Phase II trial, the investigators will evaluate the combination of gemcitabine, carboplatin, and panitumumab in the treatment of patients with metastatic triple-negative breast cancer. In addition, to assess the efficacy of this combination, tumor tissue will be examined for the presence of various markers, including K-ras and PI3K-activating mutations, EGFR, PTEN, and p53. Correlation of tumor response with marker expression may define a patient subset that is particularly responsive to treatment with a panitumumab-containing combination.

Metastatic Breast Cancer

SCRI Development Innovations, LLC71 participantsStarted Feb 2010

Thousand Oaks, California, United States • Aventura, Florida, United States • Fort Myers, Florida, United States +14 more locations

COMPLETEDPHASE2< 1 mile

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

NCT00043017

RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study the effectiveness of MRI in monitoring tumor response in women who are receiving chemotherapy for stage III breast cancer.

Breast Cancer

American College of Radiology Imaging Network356 participantsStarted May 2002

Birmingham, Alabama, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +8 more locations

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

Breast Cancer Trials in Other Cities

Nutrition Intervention in Treating Women With Breast Cancer

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Other Conditions in Dallas